4.5 Article

Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis

期刊

GENES AND IMMUNITY
卷 13, 期 6, 页码 458-460

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/gene.2012.15

关键词

systemic sclerosis; FCGR3B; copy number; polymorphism; association

资金

  1. Health Research Council of NZ
  2. NZ Lottery Health
  3. Spanish Ministry of Science [SAF2009-11110]
  4. Junta de Andalucia, Spain [CTS-4977]
  5. Redes Tematicas de Investigacion Cooperativa Sanitaria Programme
  6. (RIER) from Instituto de Salud Carlos III (ISCIII), Spain [RD08/0075]
  7. Fondo Europeo de Desarrollo Regional (FEDER)

向作者/读者索取更多资源

There is increasing evidence that gene copy number (CN) variation influences clinical phenotype. The low-affinity Fc receptor 3B (FCGR3B) located in the FCGR gene cluster is a CN polymorphic gene involved in the recruitment of polymorphonuclear neutrophils to sites of inflammation and their activation. Given the genetic overlap between systemic lupus erythematosus and systemic sclerosis (SSc) and the strong evidence for FCGR3B CN in the pathology of SLE, we hypothesised that FCGR3B gene dosage influences susceptibility to SSc. We obtained FCGR3B deletion status in 777 European Caucasian cases and 1000 controls. There was an inverse relationship between FCGR3B CN and disease susceptibility. CN of <= 1 was a significant risk factor for SSc (OR = 1.55 (1.13-2.14), P = 0.007) relative to CN >= 2. Although requiring replication, these results suggest that impaired immune complex clearance arising from FCGR3B deficiency contributes to the pathology of SSc, and FCGR3B CN variation is a common risk factor for systemic autoimmunity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据